US Patent Issued to SBI Biotech on July 21 for "TLR9 agonists" (Japanese Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,870, issued on July 21, was assigned to SBI Biotech Co. Ltd. (Tokyo).

"TLR9 agonists" was invented by Eiji Esashi (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides novel oligonucleotides and therapeutic use thereof. The oligonucleotides of the present invention can be used for the activation or modulation of immunity in the subject."

The patent was filed on Jan. 8, 2021, under Application No. 17/787,687.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=P...